Gene · 2813
GP2: glycoprotein 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GP2: glycoprotein 2. Genes, record 2813. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2813
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P55259 | Pancreatic secretory granule membrane major glycoprotein GP2 | 537 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents55
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026508054 A | 2026-03-10 | 28 | P55259 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 48041 | P55259 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 10449 | P55259 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10771 | P55259 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 6113 | P55259 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1756 | P55259 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6524 | P55259 | Espacenet |
| EP 4608873 A1 | 2025-09-03 | 28 | P55259 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1756 | P55259 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6524 | P55259 | Espacenet |
1 to 10 of 55
See all 55 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,628
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GP2 papers | Newest fiscal year |
|---|---|---|---|
| ZIAAI001089 | Viral Hemorrhagic Fevers: Disease Modeling and Transmission | 19 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| UC7AI094660 | Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed) | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 6 | 2025 |
| U19AI135995 | Center for Viral Systems Biology (CViSB) | 6 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 5 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 5 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,628Source NIH's project files
See all 1,628 nih grantsPapers2,809
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reduced fecal GP2 levels in ulcerative colitis associate with inflammatory activity and microbial composition. | Clin Chim Acta | 2027 | 42486317 | PubTator, text mining | PubMed |
| Dosimetric impact of coplanar and non-coplanar arc arrangements in VMAT-based lung SABR. | J Med Imaging Radiat Sci | 2026 | 42753370 | PubTator, text mining | PubMed |
| Development and immunological evaluation of a multi-antigen recombinant adenovirus vaccine candidate against PRRSV and PCV2. | BMC Vet Res | 2026 | 42675487 | PubTator, text mining | PubMed |
| Translating viral genetic data to PRRSV-2 cross-neutralization using machine learning. | Front Immunol | 2026 | 42500660 | PubTator, text mining | PubMed |
| Configurationally Locked Ridaifen-B Analogs as Potent Ebola Virus Entry Inhibitors. | J Med Chem | 2026 | 42475249 | PubTator, text mining | PubMed |
| Exposome factors predict the association between sleep health and depression. | medRxiv | 2026 | 42428082 | PubTator, text mining | PubMed |
| Long-term disease control of GP2-NTRK1 fusion-positive pancreatic adenocarcinoma with liver metastases using sequential tyrosine receptor kinase inhibitors. | Clin J Gastroenterol | 2026 | 42412359 | PubTator, text mining | PubMed |
| GCH1 p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations. | medRxiv | 2026 | 42396327 | PubTator, text mining | PubMed |
| Signal peptide cleavage and ectodomain regions of GP2 are required for PRRSV infection. | J Gen Virol | 2026 | 42313464 | PubTator, text mining | PubMed |
| In silico prioritization and cheminformatics identify structurally diverse small-molecule inhibitors of Lassa virus glycoprotein-mediated membrane fusion. | SLAS Discov | 2026 | 42285356 | PubTator, text mining | PubMed |
1 to 10 of 2,809
See all 2,809 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2813
GET https://conductscience.org/api/genes/v1/2813/patents?page=2